Article Text

Download PDFPDF
A clinical pathway reduced length of stay, time to ambulation, and complications after hip and knee arthroplasty

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

OpenUrlPubMedWeb of Science

Question Does the use of a clinical pathway improve patient outcomes after hip or knee arthroplasty?

Design

Randomised, unblinded, controlled trial with ≥3 months follow up.

Setting

A tertiary referral hospital in Melbourne, Victoria, Australia.

Patients

175 patients who had hip or knee arthroplasty between January 1996 and December 1997. 12 patients (6.9%) were excluded after randomisation because they were having revision arthroplasty, simultaneous bilateral joint arthroplasty, arthroplasty for acute trauma, or complex tumour surgery. The remaining 163 patients (mean age 66 y, 66% women) completed ≥3 months of follow up.

Intervention

92 patients were allocated to the clinical pathway group and 71 were allocated to the control group. Patients in the clinical pathway group received “proactive” treatment whereby specific …

View Full Text

Footnotes

  • Source of funding: no external funding.

  • For correspondence: Professor P F Choong, Department of Orthopaedics, St Vincent's Hospital, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia. Fax +61 3 9415 8677.